Risk-Adapted Approach to clinical trials and Risk Assessments
The MHRA have implemented a dual strategy for a risk-adapted approach to clinical trials in the UK.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 28 January 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (15 mars 2022). Risk-Adapted Approach to clinical trials and Risk Assessments. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o5vz





